癌症支持护理的全球差异:一项国际调查
Alexandre Chan1,2, Lawson Eng3, Changchuan Jiang4
1School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, USA.
Cancer medicine
|September 13, 2024
概括
在低收入和中等收入国家 (LMIC) 和高收入国家 (HIC) 之间,全球癌症支持性护理的准入有很大差异. 关键的差异包括药物负担能力和指导方针的实施,特别是在LMIC.
科学领域:
- 在瘤学瘤学.
- 全球健康 全球健康
- 健康差异 在健康上的差异
背景情况:
- 全球癌症负担的增加不成比例地影响低收入和中等收入国家 (LMIC).
- 在了解支持性护理获取差异方面存在重大研究差距.
- 多国癌症支持护理协会 (MASCC) 的健康差异委员会发起了一项全球调查,以解决这一差距.
研究的目的:
- 调查和描述在支持性护理获得的差异.
- 探索和比较LMIC和高收入国家 (HIC) 之间的支持性护理获取差异.
主要方法:
- 一个在线的,横截面的调查分发给了MASCC的活跃成员.
- 调查包括社会人口统计数据,临床服务的区域差异以及受影响的人口群体.
- 统计分析使用了奇平方/费舍尔精确测试和多变量逻辑回归.
主要成果:
- 218名MASCC成员参加;26.6%来自LMIC.
- 及时的癌症护理 (43.7%) 和支持性护理 (45.0%) 被确定为主要的全球差异.
- 低低收入国家参与者强调了癌症药物负担能力和指导方针实施 (56.4%每项) 是关键问题.
- 经济弱势群体在LMIC和HIC都面临差异;美国受访者指出种族/民族少数群体.
结论:
- 在LMIC和HIC之间存在癌症支持性护理的显著差异.
- 药物负担能力和指导方针的实施是LMIC的关键问题.
- 有针对性的干预措施是必要的,以解决癌症支持性护理的区域差异.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Nursing Ethical Principles II
934
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
934
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


